Medical Research
(H50)
IRS Verified
DX Registered
990 on File
CHRISTOPHER REEVE FOUNDATION A NEW JERSEY NONPROFIT CORPORATION
Financial strength (30%)
75/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy.
Financial Overview — FY 2025
$22.6M
Total Revenue
$16.4M
Total Expenses
$29.4M
Net Assets
59
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.0%
Fundraising Efficiency
723.3%
Operating Reserve
21.47x
Liability-to-Asset
5.0%
Revenue Diversification
99.4%
Executive Compensation
$1.4M
Compared with Peers
FY 2025
Compared with 46 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.0% | 81.5% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.0% | 11.8% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
10.0% | 0.2% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
723.3% | 1489.8% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
21.5 mo | 18.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
5.0% | 22.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.4% | 84.5% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
9.7% | 7.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
90.6% | 5.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
27.3% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $22.6M | $16.4M | $29.4M | 86.0% | 59 |
| 2024 | $20.6M | $8.6M | $23.1M | 87.3% | 0 |
| 2023 | $17.8M | $14.9M | $9.4M | 84.9% | 61 |
| 2022 | $16.2M | $15.1M | $7.9M | 85.2% | 56 |
| 2021 | $16.8M | $14.4M | N/A | — | 45 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.